Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...
The past year marked a period of sustained momentum for India’s healthcare and pharmaceutical sector, supported by rising ...
TORONTO, Dec. 2, 2025 /CNW/ -- Katalyze AI today announced the appointment of Hannes Bretschneider as Chief AI Officer. Hannes will lead the development of Agentic AI architecture and expand the ...
Novartis operates globally in pharmaceuticals, focusing on therapeutic development, clinical research, and manufacturing, ...
Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for ...
The study makes clear that regulators expect human oversight to remain central to pharmaceutical quality assurance. Human operators must participate at key control points and retain authority to ...
Commvault Systems is positioned as a leading cyber resiliency and data backup provider. Click here to read why CVLT stock is ...
Detailed price information for Nervgen Pharma Corp (NGEN-X) from The Globe and Mail including charting and trades.
Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback